Ole Hauch

2.1k total citations
53 papers, 1.7k citations indexed

About

Ole Hauch is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Ole Hauch has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 26 papers in Internal Medicine and 14 papers in Surgery. Recurrent topics in Ole Hauch's work include Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Ole Hauch is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Ole Hauch collaborates with scholars based in United States, Denmark and United Kingdom. Ole Hauch's co-authors include Gail Wygant, Torben Jørgensen, Lars Nannestad Jørgensen, Mark Friedman, Joseph Menzin, Matthew W. Reynolds, Vincent J. Willey, Michael Bullano, Luba Nalysnyk and Kyle Fahrbach and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Ole Hauch

52 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Hauch United States 23 1.2k 800 353 228 197 53 1.7k
Nathan P. Clark United States 22 1.3k 1.1× 1.1k 1.4× 305 0.9× 104 0.5× 197 1.0× 62 2.2k
Alex Gold United States 20 1.1k 1.0× 945 1.2× 487 1.4× 148 0.6× 201 1.0× 42 2.0k
Paul P. Dobesh United States 23 1.3k 1.2× 981 1.2× 432 1.2× 72 0.3× 227 1.2× 95 2.2k
Isabelle Mahé France 27 1.5k 1.3× 1.3k 1.6× 385 1.1× 122 0.5× 224 1.1× 171 2.4k
Gail Wygant United States 18 784 0.7× 476 0.6× 189 0.5× 153 0.7× 128 0.6× 41 1.2k
Antonio Gómez‐Outes Spain 20 970 0.8× 738 0.9× 233 0.7× 71 0.3× 127 0.6× 47 1.5k
Hemant Phatak United States 22 1.0k 0.9× 390 0.5× 187 0.5× 277 1.2× 158 0.8× 87 1.7k
Tammy J. Bungard Canada 16 961 0.8× 357 0.4× 183 0.5× 242 1.1× 219 1.1× 68 1.4k
Carmen Suárez Spain 22 1.0k 0.9× 709 0.9× 465 1.3× 144 0.6× 304 1.5× 87 1.8k
Gianluigi Devoto Italy 9 992 0.9× 675 0.8× 316 0.9× 59 0.3× 186 0.9× 12 1.5k

Countries citing papers authored by Ole Hauch

Since Specialization
Citations

This map shows the geographic impact of Ole Hauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Hauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Hauch more than expected).

Fields of papers citing papers by Ole Hauch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Hauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Hauch. The network helps show where Ole Hauch may publish in the future.

Co-authorship network of co-authors of Ole Hauch

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Hauch. A scholar is included among the top collaborators of Ole Hauch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Hauch. Ole Hauch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janzon, Magnus, Martin Henriksson, Ole Hauch, et al.. (2010). Abstract 17295: Health Economics in the PLATelet inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns. Circulation. 122. 4 indexed citations
2.
Boccuzzi, Stephen J., John Martin, Judith Stephenson, et al.. (2009). Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed. Current Medical Research and Opinion. 25(12). 2853–2864. 26 indexed citations
3.
Boulanger, Luke, Ji Soo Kim, Mark Friedman, et al.. (2006). Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice. International Journal of Clinical Practice. 60(3). 258–264. 77 indexed citations
4.
Sarawate, Chaitanya, Mirko Sikirica, Vincent J. Willey, Michael Bullano, & Ole Hauch. (2006). Monitoring anticoagulation in atrial fibrillation. Journal of Thrombosis and Thrombolysis. 21(2). 191–198. 30 indexed citations
5.
Jaime, J., Judith A. O’Brien, Jennifer Kim, et al.. (2005). Economic Implications of Extended-Release Metoprolol Succinate for Heart Failure in the MERIT-HF Trial: A US Perspective of the MERIT-HF Trial. Journal of Cardiac Failure. 11(9). 647–656. 20 indexed citations
6.
Knight, Kevin, John Wong, Ole Hauch, et al.. (2005). Economic and Utilization Outcomes Associated with Choice of Treatment for Venous Thromboembolism in Hospitalized Patients. Value in Health. 8(3). 191–200. 29 indexed citations
7.
Harley, Carolyn, et al.. (2005). Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis. Current Medical Research and Opinion. 21(2). 215–222. 10 indexed citations
8.
Menzin, Joseph, Luke Boulanger, Ole Hauch, et al.. (2005). Quality of Anticoagulation Control and Costs of Monitoring Warfarin Therapy among Patients with Atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study. Annals of Pharmacotherapy. 39(3). 446–451. 67 indexed citations
9.
Samsa, Greg, David B. Matchar, Rowena J Dolor, et al.. (2004). A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation.. Health and Quality of Life Outcomes. 2(1). 22–22. 82 indexed citations
10.
Wittkowsky, Ann K., Stephen J. Boccuzzi, Jenifer Wogen, et al.. (2004). Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(12). 1668–1674. 60 indexed citations
11.
Reynolds, Matthew W., Kyle Fahrbach, Ole Hauch, et al.. (2004). Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation. CHEST Journal. 126(6). 1938–1945. 200 indexed citations
12.
Willey, Vincent J., Michael Bullano, Ole Hauch, et al.. (2004). Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting. Clinical Therapeutics. 26(7). 1149–1159. 69 indexed citations
13.
Gross, Cary P., et al.. (2003). Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional survey. Clinical Therapeutics. 25(6). 1750–1764. 87 indexed citations
14.
Jørgensen, Torben, Lars C. Borris, Michael R. Lassen, et al.. (1992). Potential Influence of Observer Variation in Thromboprophylactic Trials. Pathophysiology of Haemostasis and Thrombosis. 22(4). 211–215. 12 indexed citations
15.
Lassen, Michael R., Lars C. Borris, Hans B. Rahr, et al.. (1991). Biologic Tolerance of Two Different Low Molecular Weight Heparins. Seminars in Thrombosis and Hemostasis. 17(4). 450–454. 26 indexed citations
16.
Borris, Lars C., Michael R. Lassen, Jeanine M. Walenga, et al.. (1991). Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty. Thrombosis Research. 63(1). 21–28. 12 indexed citations
17.
Hoffmann, J, et al.. (1989). Prospective Controlled Vagotomy Trial for Duodenal Ulcer. Results After 11–15 Years. Annals of Surgery. 209(1). 40–45. 25 indexed citations
18.
Hoffmann, J, et al.. (1989). [A prospective controlled study of vagotomy in the treatment of duodenal ulcer. Results after 11-15 years].. PubMed. 151(13). 812–4. 7 indexed citations
19.
Hauch, Ole, et al.. (1988). Plasma cross-linked fibrin degradation products fraction D in patients undergoing elective abdominal surgery. Thrombosis Research. 51(4). 385–389. 10 indexed citations
20.
Jørgensen, Torben & Ole Hauch. (1987). [Thromboembolic prevention in surgical departments in Denmark. Use and economic consequences].. PubMed. 149(27). 1811–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan P. Clark Breakdown of academic impact, for papers by Alex Gold Breakdown of academic impact, for papers by Paul P. Dobesh Breakdown of academic impact, for papers by Isabelle Mahé Breakdown of academic impact, for papers by Gail Wygant Breakdown of academic impact, for papers by Antonio Gómez‐Outes Breakdown of academic impact, for papers by Hemant Phatak Breakdown of academic impact, for papers by Tammy J. Bungard Breakdown of academic impact, for papers by Carmen Suárez Breakdown of academic impact, for papers by Gianluigi Devoto
Rankless by CCL
2026